ATS Corporation today announced that it has acquired Odyssey Validation Consultants Limited, an Ireland-based provider of digitalization solutions for the life science industry. The financial terms of the transaction were not disclosed.
Odyssey will join ATS’ Process Automation Solutions business, a leading provider of automation and digitalization solutions for the process and manufacturing industries. Odyssey’s strong focus on supporting customers in the life science industry in their compliant digital transformation and journey to cloud, will help accelerate PA’s strategy to drive validated production process improvements through digital solutions. This acquisition allows PA to expand its value proposition in the highly attractive life science end-market through delivering qualified and validated digitalization and automation solutions.
“Odyssey’s strong expertise in computer system validation and cloud-based software solutions can be offered to our existing customers in the life science industry as a value-add to our current platform, AI and ML-based software solutions, advanced data analytics capabilities, and domain knowledge,” said Dr. Christian Debus, President of PA. “Together we can leverage our capabilities and solutions to drive continuous improvement in regulated production processes for our customers across all industry sectors. We welcome the Odyssey team to PA.”
“Digital transformation is playing a key role in accelerating the delivery of new and innovative treatments for patients, with compliance being key for patient safety, product quality, and data integrity,”‘ said Oisin Curran & Fionnan Friel, Founders of Odyssey. “Combining our people and products with that of PA Solutions, along with their global reach, can enable us to accelerate digital transformation in the life science industry and shorten time to market for new treatments for patients.”
More news from the life-science industry:
Fortis Life Sciences completes acquisition of International Point of Care
Sight Sciences appoints Catherine Mazzacco to its Board of Directors
TMG appoints Ajay Nair as president of TMG Search APAC
HKSTP and AstraZeneca sign MOU on Strategic Collaboration
Pendulum Therapeutics announces Strategic Partnership and USD 10Mln investment from Fonterra
Biosyngen opens new cell therapy GMP facility in Singapore
Top global health and fitness trends for 2023
